Everything you need to support your GLP-1 journey — from supplements and fitness to telehealth, nutrition, and beyond. Covering all 50 states and serving millions of Americans on GLP-1 medications.
Comprehensive guides covering every aspect of your GLP-1 medication journey, from day one through long-term maintenance.
Understanding the medications transforming weight management across America and around the world.
GLP-1 (glucagon-like peptide-1) receptor agonists are a class of medications originally developed to treat Type 2 diabetes that have revolutionized weight management. Medications like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) work by mimicking hormones that regulate appetite, blood sugar, and digestion — producing average weight losses of 15–22% of body weight in clinical trials.
With over 7 million Americans now on GLP-1 medications — and that number growing rapidly — a rich ecosystem of support services has emerged to help users maximize their outcomes, manage side effects, preserve muscle mass, and navigate the profound physical and psychological changes that accompany this transformation.
GLP-1 users include adults with Type 2 diabetes (Ozempic, Mounjaro), adults with obesity or overweight with a related condition (Wegovy, Zepbound), and increasingly, individuals seeking cardiovascular risk reduction. Major usage hubs include major metro areas — New York, Los Angeles, Chicago, Houston, Phoenix, Dallas, Miami, Seattle, Boston, and Atlanta — but access is growing in smaller cities and rural communities through telehealth.
GLP-1 medications are FDA-approved prescription drugs that must be obtained through a licensed healthcare provider. They are not appropriate for everyone and carry potential side effects including nausea, vomiting, pancreatitis, and thyroid concerns. Always consult a qualified physician before starting any GLP-1 medication or related supplement program.
This resource hub is designed to help GLP-1 users across all 50 states — from Alabama to Wyoming, from rural communities to major urban centers — find the products, services, and information they need to thrive on their GLP-1 journey.